Poret, B., Desrues, L., Bonin, M., Pedard, M., Dubois, M., Leduc, R., . . . Gandolfo, P. (2020). Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours. MDPI AG.
Chicago Style (17th ed.) CitationPoret, Benjamin, et al. Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours. MDPI AG, 2020.
MLA (9th ed.) CitationPoret, Benjamin, et al. Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours. MDPI AG, 2020.
Warning: These citations may not always be 100% accurate.